The Nasdaq Biotech Index has rallied 22% since its 2016 low on June 27th.  We just sent paid subscribers our Chart of the Day analyzing Biotech’s recent bounce and whether it can last.  We also feature one stock we currently like in the group.  To see the report, please start a 14-day free trial to Bespoke’s paid research below.


Print Friendly, PDF & Email